{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:06:58Z","timestamp":1790906818500,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016067","name":"Shaanxi Administration of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["SZY-KJCYC-2023-085"],"award-info":[{"award-number":["SZY-KJCYC-2023-085"]}],"id":[{"id":"10.13039\/100016067","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273795"],"award-info":[{"award-number":["82273795"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104649"],"award-info":[{"award-number":["82104649"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.prp.2026.156482","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T15:45:53Z","timestamp":1776959153000},"page":"156482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Sennoside A alleviates HFD-induced MAFLD by protecting intestinal barrier function through TLR4\/NF-\u03baB and mitochondrial quality control"],"prefix":"10.1016","volume":"283","author":[{"given":"Li","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyue","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongning","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2026.156482_bib1","first-page":"51","article-title":"The art of writing a scientific article","volume":"163","author":"Cao","year":"2020","journal-title":"J. Sci. Commun."},{"issue":"3","key":"10.1016\/j.prp.2026.156482_bib2","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/j.cgh.2021.02.030","article-title":"Estimating global prevalence of metabolic dysfunction-associated fatty liver disease in overweight or obese adults","volume":"20","author":"Liu","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.prp.2026.156482_bib3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/gutjnl-2021-324915","article-title":"Italian Liver Cancer (ITA.LI.CA) group, Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database","volume":"72","author":"Vitale","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.prp.2026.156482_bib4","doi-asserted-by":"crossref","DOI":"10.1177\/20420188221145549","article-title":"MAFLD: a multisystem disease","volume":"14","author":"Pipitone","year":"2023","journal-title":"Ther. Adv. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.prp.2026.156482_bib5","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2331460","article-title":"Breaking the barriers: the role of gut homeostasis in metabolic-associated steatotic liver disease (MASLD)","volume":"16","author":"Bened\u00e9-Ubieto","year":"2024","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.prp.2026.156482_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41392-024-01797-1","article-title":"METTL14 downregulation drives S100A4+ monocyte-derived macrophages via MyD88\/NF-\u03baB pathway to promote MAFLD progression","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.prp.2026.156482_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105482","article-title":"Microbiome and metabolomics reveal the effect of gut microbiota on liver regeneration of fatty liver disease","volume":"111","author":"Hu","year":"2025","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.prp.2026.156482_bib8","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.7150\/ijbs.86465","article-title":"The role of STAT3\/VAV3 in glucolipid metabolism during the development of HFD-induced MAFLD","volume":"20","author":"Jiang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.prp.2026.156482_bib9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41522-023-00451-y","article-title":"Inulin-enriched Megamonas funiformis ameliorates metabolic dysfunction-associated fatty liver disease by producing propionic acid","volume":"9","author":"Yang","year":"2023","journal-title":"NPJ Biofilms Micro"},{"issue":"11","key":"10.1016\/j.prp.2026.156482_bib10","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","article-title":"Gut-liver axis: pathophysiological concepts and clinical implications","volume":"34","author":"Tilg","year":"2022","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.prp.2026.156482_bib11","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1159\/000502112","article-title":"Isoproterenol disrupts intestinal barriers activating gut-liver-axis: effects on intestinal mucus and vascular barrier as entry sites","volume":"101","author":"Sorribas","year":"2020","journal-title":"Digestion"},{"key":"10.1016\/j.prp.2026.156482_bib12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","article-title":"Inflammatory mechanisms in obesity","volume":"29","author":"Gregor","year":"2011","journal-title":"Annu. Rev. Immunol."},{"issue":"18","key":"10.1016\/j.prp.2026.156482_bib13","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1042\/CS20220572","article-title":"Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways","volume":"136","author":"Badmus","year":"2022","journal-title":"Clin. Sci. (Lond. )"},{"issue":"1","key":"10.1016\/j.prp.2026.156482_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","article-title":"Inflammation in obesity, diabetes, and related disorders","volume":"55","author":"Rohm","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.prp.2026.156482_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102569","article-title":"Silica nanoparticles aggravated the metabolic associated fatty liver disease through disturbed amino acid and lipid metabolisms-mediated oxidative stress","volume":"59","author":"Abulikemu","year":"2023","journal-title":"Redox Biol."},{"issue":"4","key":"10.1016\/j.prp.2026.156482_bib16","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.jhep.2022.06.012","article-title":"Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits","volume":"77","author":"Peiseler","year":"2022","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.prp.2026.156482_bib17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s40168-021-01107-9","article-title":"Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis","volume":"9","author":"Zhao","year":"2021","journal-title":"Microbiome"},{"issue":"6","key":"10.1016\/j.prp.2026.156482_bib18","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S2468-1253(24)00390-X","article-title":"The intestinal barrier: a pivotal role in health, inflammation, and cancer","volume":"10","author":"Neurath","year":"2025","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.prp.2026.156482_bib19","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s12072-010-9219-x","article-title":"The role of lipopolysaccharide\/toll-like receptor 4 signaling in chronic liver diseases","volume":"21","author":"Soares","year":"2010","journal-title":"Hep. Int."},{"key":"10.1016\/j.prp.2026.156482_bib20","doi-asserted-by":"crossref","first-page":"G270","DOI":"10.1152\/ajpgi.00304.2014","article-title":"Hepatic TLR4 signaling in obese NAFLD","volume":"309","author":"Sharifnia","year":"2015","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.prp.2026.156482_bib21","article-title":"The potential of medicinal food plant Panax ginseng C. A. Mey. in managing chronic diseases via gut microbiota regulation: a systematic review of mechanisms and evidence","volume":"16","author":"Gao","year":"2025","journal-title":"Front. Pharm."},{"key":"10.1016\/j.prp.2026.156482_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2024.127838","article-title":"The role of intestinal microbiota and metabolites in intestinal inflammation","volume":"288","author":"Ma","year":"2024","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.prp.2026.156482_bib23","article-title":"Macrophage polarization: an important role in inflammatory diseases","volume":"15","author":"Luo","year":"2024","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.prp.2026.156482_bib24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41577-022-00760-x","article-title":"Mitochondrial control of inflammation","volume":"23","author":"Marchi","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.prp.2026.156482_bib25","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1152\/physrev.00058.2021","article-title":"Mitochondria in health, disease, and aging","volume":"103","author":"Harrington","year":"2023","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.prp.2026.156482_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13920","article-title":"Mitochondria-derived damage-associated molecular patterns and inflammation in the ischemic-reperfused heart","volume":"237","author":"Torp","year":"2023","journal-title":"Acta Physiol. (Oxf. )"},{"key":"10.1016\/j.prp.2026.156482_bib27","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41419-021-03752-2","article-title":"Mitochondrial fission and mitophagy are independent mechanisms regulating ischemia\/reperfusion injury in primary neurons","volume":"12","author":"Anzell","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.prp.2026.156482_bib28","doi-asserted-by":"crossref","first-page":"11196","DOI":"10.3390\/ijms252011196","article-title":"Apoptosis, mitochondrial autophagy, fission, and fusion maintain mitochondrial homeostasis in mouse liver under tail suspension conditions","volume":"25","author":"Li","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.prp.2026.156482_bib29","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.apsb.2019.01.014","article-title":"Regulation of microbiota-GLP1 axis by sennoside A in diet-induced obese mice","volume":"9","author":"Le","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.prp.2026.156482_bib30","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.2147\/DMSO.S247251","article-title":"induces GLP-1 secretion through activation of the ERK1\/2 pathway in L-cells, Diabetes Metab","volume":"13","author":"Ma","year":"2020","journal-title":"Syndr. Obes."},{"issue":"2","key":"10.1016\/j.prp.2026.156482_bib31","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.bbrc.2018.04.108","article-title":"protects mitochondrial structure and function to improve high-fat diet-induced hepatic steatosis by targeting VDAC1","volume":"500","author":"Le","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.prp.2026.156482_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105909","article-title":"Toosendanin alleviates dextran sulfate sodium-induced colitis by inhibiting M1 macrophage polarization and regulating NLRP3 inflammasome and Nrf2\/HO-1 signaling","volume":"76","author":"Fan","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.prp.2026.156482_bib33","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.apsb.2021.10.023","article-title":"NF-\u03baB regulates brown adipocyte function through suppression of ANT2","volume":"12","author":"Peng","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"10","key":"10.1016\/j.prp.2026.156482_bib34","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1111\/1751-7915.14293","article-title":"Akkermansia muciniphila alleviates high-fat-diet-related metabolic-associated fatty liver disease by modulating gut microbiota and bile acids","volume":"16","author":"Wu","year":"2023","journal-title":"Microb. Biotechnol."},{"issue":"4","key":"10.1016\/j.prp.2026.156482_bib35","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3390\/biomedicines13040802","article-title":"Electroacupuncture attenuates intestinal barrier disruption via the \u03b17nAChR-mediated HO-1\/p38 MAPK\/NF-\u03baB pathway in a mouse model of metabolic dysfunction-associated fatty liver disease: a randomized, single-blind, controlled trial","volume":"13","author":"Wang","year":"2025","journal-title":"Biomedicines"},{"issue":"12","key":"10.1016\/j.prp.2026.156482_bib36","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1007\/s40279-023-01918-w","article-title":"Exercise in the management of metabolic-associated fatty liver disease (MAFLD) in adults: a position statement from exercise and sport science australia","volume":"53","author":"Keating","year":"2023","journal-title":"Sports Med."},{"key":"10.1016\/j.prp.2026.156482_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1087260","article-title":"Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)","volume":"13","author":"Rong","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.prp.2026.156482_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1081096","article-title":"Effects of lifestyle intervention on adults with metabolic associated fatty liver disease: a systematic review and meta-analysis","volume":"14","author":"Chai","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"10464","key":"10.1016\/j.prp.2026.156482_bib39","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(24)01811-7","article-title":"Steatotic liver disease","volume":"404","author":"Israelsen","year":"2024","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.prp.2026.156482_bib40","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.jhep.2022.06.012","article-title":"Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits","volume":"77","author":"Peiseler","year":"2022","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.prp.2026.156482_bib41","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","article-title":"Gut-liver axis: pathophysiological concepts and clinical implications","volume":"34","author":"Tilg","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.prp.2026.156482_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112678","article-title":"The links between gut microbiota and obesity and obesity related diseases","volume":"147","author":"Geng","year":"2022","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.prp.2026.156482_bib43","article-title":"Baicalin mitigates hyperglycemia-linked intestinal epithelial barrier impairment in part by inhibiting the formation of neutrophil extracellular traps","volume":"16","author":"Cai","year":"2025","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.prp.2026.156482_bib44","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.3390\/cells9102162","article-title":"At the forefront of the mucosal barrier: the role of macrophages in the intestine","volume":"9","author":"Ruder","year":"2020","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.prp.2026.156482_bib45","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.tem.2022.01.002","article-title":"Gut barrier disruption and chronic disease","volume":"33","author":"Martel","year":"2022","journal-title":"Trends Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.prp.2026.156482_bib46","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/gutjnl-2020-323071","article-title":"Gut microbiota-derived metabolites as central regulators in metabolic disorders","volume":"70","author":"Agus","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.prp.2026.156482_bib47","doi-asserted-by":"crossref","first-page":"29247","DOI":"10.1021\/acs.jafc.5c05587","article-title":"Potential effects of functional foods and dietary supplements on metabolic-associated fatty liver disease and the underlying mechanisms: a narrative review with a focus on the modulation of the gut microbiota","volume":"73","author":"Chang","year":"2025","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.prp.2026.156482_bib48","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186423","article-title":"Metabolic dysfunction-associated steatotic liver disease and the gut microbiome: pathogenic insights and therapeutic innovations","volume":"135","author":"Schnabl","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.prp.2026.156482_bib49","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12876-024-03277-w","article-title":"Metabolites mediate the causal associations between gut microbiota and NAFLD: a mendelian randomization study","volume":"24","author":"Ouyang","year":"2024","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.prp.2026.156482_bib50","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.3390\/ijms25084387","article-title":"Alteration of gut microbiota composition in the progression of liver damage in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"25","author":"Zazueta","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2026.156482_bib51","article-title":"Integrated microbiome and metabolomics analysis reveals therapeutic efficacy and underlying mechanisms of Weizmannia coagulans on inflammation in Helicobacter pylori-infected mice","author":"Wu","year":"2025","journal-title":"J. Future Foods"},{"issue":"11","key":"10.1016\/j.prp.2026.156482_bib52","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1016\/j.cell.2024.04.037","article-title":"Mitochondria at the crossroads of health and disease","volume":"187","author":"Suomalainen","year":"2024","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.prp.2026.156482_bib53","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-021-00433-y","article-title":"Molecular mechanisms and consequences of mitochondrial permeability transition","volume":"23","author":"Bonora","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"15","key":"10.1016\/j.prp.2026.156482_bib54","doi-asserted-by":"crossref","first-page":"12295","DOI":"10.3390\/ijms241512295","article-title":"The reduction in the mitochondrial membrane potential in aging: the role of the mitochondrial permeability transition pore","volume":"24","author":"Rottenberg","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.prp.2026.156482_bib55","first-page":"32","article-title":"Mitochondrial quality control in human health and disease","volume":"11","author":"Liu","year":"2024","journal-title":"Mil. Med. Res."},{"issue":"2","key":"10.1016\/j.prp.2026.156482_bib56","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s11010-024-05042-9","article-title":"Mitophagy in relation to chronic inflammation\/ROS in aging","volume":"480","author":"Kong","year":"2025","journal-title":"Mol. Cell Biochem."},{"issue":"1","key":"10.1016\/j.prp.2026.156482_bib57","doi-asserted-by":"crossref","DOI":"10.1111\/imr.13410","article-title":"Regulation of the NLRP3 inflammasome by autophagy and mitophagy","volume":"329","author":"Gupta","year":"2025","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.prp.2026.156482_bib58","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020104705","article-title":"Molecular mechanisms and physiological functions of mitophagy","volume":"40","author":"Onishi","year":"2021","journal-title":"EMBO J."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826001354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826001354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:26:14Z","timestamp":1783124774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826001354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":58,"alternative-id":["S0344033826001354"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156482","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sennoside A alleviates HFD-induced MAFLD by protecting intestinal barrier function through TLR4\/NF-\u03baB and mitochondrial quality control","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156482","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156482"}}